News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Makoto Life Sciences, Inc. Signs $20 Million Research Collaboration With Taiho Pharmaceutical


8/2/2006 5:03:18 PM

Makoto Life Sciences, Inc. announced today that it has signed a Funded Research Agreement with Taiho Pharmaceutical Co., Ltd of Japan. Under the terms of the Agreement, which provides research funding, potential future milestone and royalty payments, the companies will collaborate and leverage Makoto’s multi-component platform for applications in small molecule target identification. Target identification is among the most challenging problems along the critical path to drug discovery and development. Makoto’s integrated approach will be utilized under the Agreement to identify targets within disease pathways in several therapeutic areas, including, oncology, urology and allergic inflammation, and will facilitate further drug development activities at Taiho.


Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES